Eloxx Pharmaceuticals Inc.

ELOX | NASDAQ

Price Alert Chart Builder DCF Calculator

$13.45

+$0.27 (+2.05%)

At close: Oct 30, 2026, 4:00 PM ET

$13.79

+$0.34 (+2.53%)

Pre-market: Nov 2, 2026, 7:12 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023	FY 2022 Dec 31, 2022	FY 2021 Dec 31, 2021	FY 2020 Dec 31, 2020
Net Income	-6M	-3.14M	-17.05M	-36.07M	-66.73M	-34.58M
Depreciation & Amortization	n/a	164K	809K	695K	960K	571K
Stock-Based Compensation	235K	541K	1.97M	n/a	n/a	n/a
Other Working Capital	794K	356K	-1.84M	-1.76M	-715K	-2.01M
Other Non-Cash Items	-1.09M	79K	-905K	3.64M	31.8M	9.24M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	520K	-2.36M	844K	-118K	-1.03M	-3.4M
Operating Cash Flow	-6.33M	-4.72M	-14.34M	-31.85M	-35M	-28.17M
Capital Expenditures	6.33M	n/a	n/a	-66K	-89K	n/a
Cash Acquisitions	1K	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	33.75M
Other Investing Acitivies	n/a	38K	309K	n/a	2.15M	42K
Investing Cash Flow	1K	38K	309K	-66K	2.06M	33.79M
Debt Repayment	1.61M	3.06M	-9.4M	n/a	491K	-3.79M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	9.39M	381K	431K	8.81M	2.56M	277K
Financial Cash Flow	11M	3.44M	-4.08M	8.81M	50.79M	-3.44M
Net Cash Flow	-14.68M	-1.24M	-18.11M	-23.1M	17.84M	2.19M
Free Cash Flow	n/a	-4.72M	-14.34M	-31.91M	-35.09M	-28.17M
Adj. Free Cash Flow	-235K	-5.26M	-16.31M	-31.91M	-35.09M	-28.17M
Maintenance CapEx	6.33M	n/a	n/a	-66K	-89K	n/a
Growth CapEx	n/a	n/a	n/a	n/a	n/a	n/a
Owner Earnings	n/a	-4.72M	-14.34M	-31.91M	-35.09M	-28.17M